Difference between revisions of "Part:BBa K4225015"

Latest revision as of 11:45, 10 October 2022

LVA-CS, a LVA tag with a TEV Cleavage Site Downstream

This is a composite part that consists of LVA tag (BBa_K880004) and a TEV protease cleavage site (BBa_K1319016).This is a composite part that is used for another composite part which is subsequently used by 2022 HKUST Team as a positive control for the characterization of our inhibitory sequence (IS) with the code BBa_K4225013. For more information on the experiment result, refer to the composite part BBa_K4225019.

Sequence and Features

Assembly Compatibility:

10
COMPATIBLE WITH RFC[10]
12
COMPATIBLE WITH RFC[12]
21
COMPATIBLE WITH RFC[21]
23
COMPATIBLE WITH RFC[23]
25
COMPATIBLE WITH RFC[25]
1000
COMPATIBLE WITH RFC[1000]

Revision as of 13:40, 9 October 2022 (view source) Registry (Talk \| contribs)		Latest revision as of 11:45, 10 October 2022 (view source) Lrsalim (Talk \| contribs)
Line 3:		Line 3:
	<partinfo>BBa_K4225015 short</partinfo>		<partinfo>BBa_K4225015 short</partinfo>

−	This is a composite part that consists of LVA tag (BBa_K880004) and a ~~ENLYFQ Cut Site~~ (BBa_K1319016)~~. The ENLYFQ Cut Site is a cut site recognized by a TEV protease~~. This is a composite part that is used for another composite part which is subsequently used by 2022 HKUST Team as a positive control for the characterization of our inhibitory sequence (IS) with the code BBa_K4225013.	+	This is a composite part that consists of LVA tag (BBa_K880004) and a TEV protease cleavage site (BBa_K1319016).This is a composite part that is used for another composite part which is subsequently used by 2022 HKUST Team as a positive control for the characterization of our inhibitory sequence (IS) with the code BBa_K4225013. For more information on the experiment result, refer to the composite part [https://parts.igem.org/Part:BBa_K4225019 BBa_K4225019.]